The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

​Precigen, Inc. (NASDAQ:PGEN) is one of the Best Rising Penny Stocks to Buy Now.

​Wall Street is bullish on Precigen, Inc. (NASDAQ:PGEN) after the company posted encouraging fiscal Q4 2025 earnings on March 25. Following the release on April 2, H.C. Wainwright reiterated a Buy rating on the stock with a $10 price target. Earlier on March 26, Citizen JMP had raised the price target on the stock from $8 to $9, while reiterating a Buy rating on the shares.

​Precigen, Inc. (NASDAQ:PGEN) transitioned from a clinical to commercial stage company in August 2025 with the FDA approval for PAPZIMEOS to treat adults with recurrent respiratory papillomatosis (RRP). During the fiscal fourth quarter of 2025, PAPZIMEOS generated $3.4 million in net sales and marked the first partial quarter of US commercial sales.

​Management noted that the Centers for Medicare & Medicaid Services has assigned a J-code J3404 to the therapy effective April 1, 2026. As a result, the company expects fiscal Q1 2026 revenue for the drug to exceed $18 million.

​Precigen, Inc. (NASDAQ:PGEN) is a biopharmaceutical company focused on developing next-generation gene and cell therapies, specifically in immuno-oncology, autoimmune disorders, and infectious diseases.

While we acknowledge the potential of PGEN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 7 Hot Growth Stocks to Invest in Right Now and 7 Ridiculously Cheap Stocks to Buy According to Wall Street Analysts. 

Disclosure: None. Follow Insider Monkey on Google News.